Methods of cytodiagnostic staging of neoplasia and squamous...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S006120, C435S007230, C530S350000

Reexamination Certificate

active

10251887

ABSTRACT:
Methods of diagnosing whether an epithelial tissue is an abnormal tissue by determining an expression pattern for PML in the epithelial tissue; determining an expression pattern for nuclear bodies in the epithelial tissue; determining SUMO-1 colocalization and comparing the expression pattern for PML and the expression pattern for nuclear bodies with a control are disclosed. Also disclosed are methods for diagnosing whether a subject has mild dysplasia, moderate dysplasia, Type A severe dysplasia, Type B severe dysplasia, cervical squamous cell carcinoma, or poorly-differentiated cervical squamous cell carcinoma, by determining an expression pattern for PML, an expression pattern for nuclear bodies, and SUMO-1 colocalization and determining whether the sample is consistent with expression patterns expected for mild dysplasia, moderate dysplasia, Type A severe dysplasia, Type B severe dysplasia, cervical squamous cell carcinoma, or poorly-differentiated cervical squamous cell carcinoma.

REFERENCES:
Kamitani T. et al. Journal of Biological Chemistry 273(41): 26675-26682, 1998.
Muller S. et al. The EMBO Journal 17(1): 61-70, 1998.
Ahn, JH, et al. (1998) “Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML” Mol. Cell Bio. 18:4899-4913.
Ahn, JH, et al. (1999) “The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODS or ND10)” J. Virol. 73:10458-10471.
Borrow, J., et al. (1990) “Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17” Science 249:1577-1580.
Brisson, J., et al (1994) “Risk factors for cervical intraepithelial neoplasia differences between low-and high-grade lesions” American Journal Epidemiology 140:700-710.
“Preinvasive disease of the cervix, vagina and vulva”, Clinical Gynecolgic Oncology, 4thEd., (1993) Di Saia, P.J. and Creasman, WT, eds. Mosby Year Book, pp. 1-47.
Doucas, V, et al (1993) “The PML-retinoic acid receptor α translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1” PNAS USA 90:9345-9349.
Duprez, E, et al. (1999) “SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localization” J. Cell Sci. 112:381-393.
Dyck, J. et al. (1994) “A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein” Cell 76:333-343.
Everett, R.D. et al. (1994) “HSV-1 IE protein Vmw110 causes redistribution of PML” EMBO J. 13:5062-5069.
Gambacorta, M, et al. (1996) “Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues” Am. J. Path. 149:2023-2035.
Goddard, AD, et al. (1991) “Characterization of a zinc finger gene disrupted by the T (15; 17) in acute promyelocytic leukemia” Science 254:1371-1374.
Gostissa, M, et al. (1999) “Activation of p53by conjugation to the eubiquitin-like protein SUMO-1” EMBO J 18:6462-6471.
He, Dalin et al. (1997) “Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells” Cancer Res. 57:1868-1872.
Hodges, M, et al. (1998) “Protein regulation: tag wrestling with relatives of ubiquitin” Current Biol. 8:749-752.
Hugues de Thé, et al. (1990) “The t (15;17) Translocation of Acute Promyelocytic leukaemia fuses the retinoic acid receptor gene to a novel transcribed locus” Nature 347:558-561.
Hughes de Thé, et al. (1991) “The PML-RARα Fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionality altered RAR” Cell 66:675-684.
Ishov, AM, et al. (1999) “PML Is Critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1” J Cell Biol. 147:221-233.
Kakizuka, A. et al. (1991) “Chromosomal Translocation t(15;17) in Human Acute Promyelocytic Leukemia Fuses RARα with a Novel Putative Transcription Factor, PML” Cell 66:663-674.
Klaes, R. et al. (2001) “Overexpression of p16INK4Aas a Specific Marker for Dysplastic and Neoplastic Epithelial Cells of the Cervice Uteri” Int. J Cancer 92:276-284.
Koken MHM, et al. (1994) “The t(15;17) Translocation Alters a Nuclear Body in a Retinoic Acid-Reversible Fashion” EMBO J 13(5):1073-7083.
Koken MHM, et al. (1995) “The PML Growth-Suppressor has an Altered Expression in Human Oncogenesis” Oncogene 10:1315-1324.
Kretz-Remy, C, et al. (1999) “SUMO/sentrin: protein modifiers regulating important cellular functions” Cell Biol. 77:299-309.
Lavau, C, et al. (1995) “The acute promyelocytic leukaemia-associated PML gene is induced by interferon” Oncogene 11:871-876.
Le, XF et al. (1996) “Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML” J Biol. Chem. 274:130-135.
Le, XF et al. (1998) “Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis” Oncogene 16:1839-1849.
Lin, R.J. (1999) “Molecular genetics of acute promyelocytic leukemia” Trends in Genetics 15:179-183.
Litvinov, SV, et al. (1996) “Expression of ep-cam in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation” Am. J Path 148:865-875.
Longo, L. et al (1990) “Rearrangements and aberrant expression of the retinoic acid receptor gene in acute promyelocytic leukemias” J Exp. Med. 172:1571-1575.
Lowy, DR et al. (1994) “Genital human papillomavirus infection” Proc. Natl. Acad. USA 19:2436-2440.
Maul, G.G, et al. (1993) “Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICPO)” J Gen. Virology, 74:2679:2690.
Maul, Gerd G, et al. (1994) “The nuclear location of PML, a cellular member of the C3HC4viral protein ICP0” J Gen. Virology 75:1223-1233.
Maul, Gerd G, et al. (1995) “Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress” J Cell. Biochem. 59:498-513.
Mu et al. (1994) “Growth suppressor function of PML in APL”, Molecular and Cellular Biology 14:6859-6867.
Mueller, S, et al. (1999) “Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption” J Virology 73:5137-5143.
Pandolfi, PP, et al. (1991) “Structure and origin of the acute promyelocytic leukemia myl/RARα cDNA and characterization of its Retinoid-binding and transactivation properties” Oncogene 6:1285-1292.
Rodriguez, MS, et al. (1999) “SUMO-1 modification activates the transcriptional response ofp53” EMBO J 18:6455-6461.
Ruggero, MS et al. (2000) “The puzzling multiple lives of PML and its role in the genesis of cancer” BioEssays 22:827-835.
Saitoh, H, et al. (1998) “Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2” Current Biology 8:121-124.
Physiological Alterations Within the Cervical Epithelium (1976) “The cervical epithelium during puberty and adolescence” by Singer, A. The Whitefriars Press Ltd. pp. 1-36.
Skyldbert, B, et al. (1999) “Laminin-5 as a marker of invasiveness in cervical lesions” J Natl. Cancer Inst. 91:1882-1887.
Sternsdorf, T, et al. (1997) “Evidence for covalent modification of the nuclear dot-associated pro

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods of cytodiagnostic staging of neoplasia and squamous... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of cytodiagnostic staging of neoplasia and squamous..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of cytodiagnostic staging of neoplasia and squamous... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3838395

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.